Loading current stock analysis…
Loading current stock analysis…
As of 18 Sept 2026, 03:30 pm
Inventurus Knowledge Solutions Limited announced on September 4, 2026, the resignation of Ms. Manisha Kadagathur from her position as Chief Human Resource Officer, effective September 4, 2026, due to personal reasons. Additionally, the company informed the exchange on September 15, 2026, about its participation in the Jefferies India Forum on September 17, 2026, in Gurgaon, stating that no unpublished price-sensitive information would be shared.
As of September 18, 2026, Inventurus Knowledge Solutions Limited's stock has shown varied returns across different timeframes. It has returned 3% over the last day and 3% over the last 10 days. Looking at longer periods, the stock has returned 6% year-to-date (YTD) and 15% over the last year. Over the last six months, the return was 32%, while it was 6% over the last three months. The stock has seen a 4% decrease over the last month and has returned 0% over the last 5 days. Since its inception, the stock has experienced an 8% decrease.
As of September 18, 2026, the daily trend for Inventurus Knowledge Solutions Limited shows a closing price of ₹1779.9. The Exponential Moving Average (EMA) for 20 days is ₹1768.94, and the Simple Moving Average (SMA) for 20 days is ₹1763.01. The Supertrend indicator is at ₹1886.49, with a 'bearish' direction. On a monthly basis, the Supertrend is ₹1043.32, indicating a 'bullish' direction. The stock's nearest resistance level is at ₹1795.97, and the nearest support level is at ₹1762.43.
As of 18 Sept 2026, 03:30 pm
Recent drawdown and price variability remain within the producer's contained-risk thresholds.
Primary driver: Price swings are higher than typical
Trading activity was substantially higher than usual and the price closed higher.
This may reflect stronger-than-usual market participation; follow-through and relevant company or market news merit review.
The session opened materially above the previous close, indicating a sharp repricing at the open.
The move may reflect new information; subsequent price follow-through is worth monitoring.
Latest complete financial results for Q1 FY2027 and comparative quarterly trends.
| Metric | Q1 FY2026-27(Latest) | Q4 FY2025-26 | Q3 FY2025-26 | Q2 FY2025-26 | Q1 FY2025-26 |
|---|---|---|---|---|---|
| Revenue From Operations | PEAK₹893.63 crore | ₹857.65 crore | ₹814.95 crore | ₹781.09 crore | ₹740.10 crore |
| Profit Before Exceptional Items And Tax | ₹256.25 crore | PEAK₹258.36 crore | ₹231.77 crore | ₹229.13 crore | ₹194.88 crore |
| Profit Before Tax | ₹256.25 crore | PEAK₹258.36 crore | ₹231.77 crore | ₹229.13 crore | ₹194.88 crore |
| Profit Loss For Period | ₹193.74 crore | PEAK₹205.97 crore | ₹183.33 crore | ₹180.72 crore | ₹151.54 crore |
| Finance Costs | ₹10.11 crore | ₹12.68 crore | PEAK₹23.34 crore | ₹16.15 crore | ₹18.08 crore |
| Other Expenses | PEAK₹143.84 crore | ₹137.67 crore | ₹127.44 crore | ₹102.28 crore | ₹106.38 crore |
IKS Health’s revenue increased for the fifth consecutive quarter, but profit before tax declined slightly from the prior quarter as expenses outpaced revenue growth. Net profit fell further due to a higher tax rate. Compared to a year ago, both revenue and profit posted double-digit increases, with comprehensive income rising more than 50%.
Revenue from operations reached ₹893.63 crore for the quarter ended 30 June 2026, up 4.2% from ₹857.65 crore in Q4 FY2025-26 and 20.7% from ₹740.10 crore in the year-ago quarter. The sequential growth rate is in line with the pace seen in recent quarters.
Revenue grew again this quarter, but profit before tax edged lower as expenses rose faster than revenue. Net profit fell more due to a higher tax rate. Compared to a year ago, both revenue and profit are significantly higher. The company’s other expenses have grown as a share of revenue over the past year, while finance costs have fallen sharply.
Exchange disclosures and regulatory announcements for Inventurus Knowledge Solutions.
Inventurus Knowledge Solutions Limited informed stock exchanges on September 15, 2026, that it will participate in the Jefferies India Forum on September 17, 2026, in Gurgaon, with multiple investors. The company stated no unpublished price-sensitive information will be shared at the meeting.
INVENTURUS KNOWLEDGE SOLUTIONS LIMITED has informed the Exchange about Schedule of Analysts or Institutional Investors Meet |SUBJECT: Analyst/Investor Meet Para A-XBRL
Inventurus Knowledge Solutions Limited reported the resignation of Ms. Manisha Kadagathur from her position as Chief Human Resource Officer, effective September 4, 2026. The company received the resignation letter on the same date, citing personal reasons for the cessation of her senior management role.
Inventurus Knowledge Solutions Limited has informed the Exchange about Resignation of Director/KMP/SMP |SUBJECT: Resignation of Director/KMP/SMP
Inventurus Knowledge Solutions Limited will hold its 20th Annual General Meeting on September 21, 2026, at 5:30 p.m. IST via video conferencing. The Board did not declare a dividend for FY 2025-26. Shareholders will vote on proposals to increase the Employee Stock Option Plan 2022 pool from 27,000,000 to 32,000,000 options and to extend the plan's benefits to employees of group, subsidiary, and associate companies.
Inventurus Knowledge Solutions Limited notified shareholders via a letter dated August 28, 2026, that the Annual Report and Notice for its 20th Annual General Meeting (AGM) are accessible online because their email addresses were not registered with the company or depositories. The AGM is scheduled to be held on September 21, 2026, at 5:30 PM IST through video conferencing, with remote e-voting open from September 17, 2026, to September 20, 2026. The cut-off date for determining entitlement to vote remotely was set as September 14, 2026.
Recent market and company developments associated with Inventurus Knowledge Solutions.
IKS Health Delivers Strong Q1 FY27 Results with 21% Year-Over-Year Revenue Growth and 28% Year-Over-Year PAT Increase
Sensex, Nifty, Share Prices LIVE: Sensex was up 160.95 pts or 0.20% to 78,741.95 at 9.16 am after opening at 78,782.43 from the previous close of 78,581; Nifty inched up 8.70 pts or 0.04% to 24,633.35.
Sensex, Nifty, Share Prices LIVE: Benchmark indices opened Tuesday’s session on a weak note, with the Nifty 50 trading lower by 175 points and the Sensex slipping modestly, as markets corrected after Monday’s sharp rally that analysts attributed partly to a technical distortion from the new Closing Auction Session mechanism.
Sensex, Nifty, Share Prices LIVE: Indian benchmark indices trade higher on Wednesday, tracking positive global cues as investors shifted focus to the earnings season. Easing oil prices, optimism over the India-UK trade pact and encouraging early corporate results further supported market sentiment.
Comprehensive Section Breakdown for Inventurus Knowledge Solutions
Strategic Vision: Technology-enabled healthcare solutions for efficient care delivery.
• Technology-enabled healthcare solutions provider
• Global team including technologists and clinical staff
• Focus on enabling efficient delivery of high-quality care
Profit before tax (PBT) was ₹256.25 crore, slightly lower than ₹258.36 crore in Q4, a decline of 0.8%. The dip in PBT despite a 4.2% revenue increase indicates that total expenses grew faster than revenue during the quarter. Year-on-year, PBT rose 31.5%, outpacing the 20.7% revenue growth, which reflects an improvement in profit margin compared to the same quarter last year.
Net profit after tax fell to ₹193.74 crore from ₹205.97 crore in Q4, a decline of 5.9%. The larger drop in net profit relative to PBT was driven by a higher tax expense. The effective tax rate increased to 22.3% in the current quarter from 18.2% in the prior quarter. Year-on-year, net profit rose 27.8%, broadly in line with PBT growth as the tax rate was similar to the year-ago period.
Other expenses were ₹143.84 crore, up 4.5% from ₹137.67 crore in Q4. Over the past year, other expenses have grown 35.2%, notably faster than the 20.7% revenue growth. As a share of revenue, other expenses rose to 16.1% in the current quarter from 14.4% in the year-ago quarter, indicating that this cost category has expanded relative to business volume.
Finance costs continued to decline, falling to ₹10.11 crore from ₹12.68 crore in Q4, a 20.3% decrease. Year-on-year, finance costs were down 44.1%. The reduction in finance costs partially offset the rise in other expenses.
Comprehensive income, which includes other comprehensive income items, was ₹239.97 crore, down 6.3% from ₹256.20 crore in Q4 but up 52.1% from ₹157.77 crore a year ago. The difference between comprehensive income and net profit was ₹46.23 crore, compared to ₹50.23 crore in the prior quarter, reflecting other comprehensive income movements.
Basic earnings per share was ₹11.55, compared to ₹12.31 in Q4 and ₹9.07 a year ago. The sequential decline of 6.2% reflects the lower net profit, while the year-on-year increase of 27.3% is consistent with net profit growth.
Category: B2B Services
Helps healthcare organizations manage financial processes from patient registration to payment collection.
Category: B2B Services
Provides assistance to clinicians, streamlining workflows and supporting patient care delivery.
Category: B2B Services
Focuses on helping healthcare providers achieve better patient outcomes and manage costs more effectively.
Core Thesis: The IKS Care Enablement Platform addresses administrative, clinical, and operational burdens in healthcare.
• Agility: Guides the company's approach to navigating opportunities. • Learning: Guides the company's approach to embedding insight. • Discovery: Guides the company's approach to pursuing innovation. • Community: Guides the company's approach to fostering collaboration.